Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by K. Lehman
Psy16 - Health Outcome Improvements in Spinal Muscular Atrophy Type 1 Patients With Avxs-101 Gene Replacement Therapy
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Related publications
Psy18 - Rapid Improvements in Motor Function in Spinal Muscular Atrophy Type 1 Following Avxs-101 Gene Replacement Therapy
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
014 AVXS-101 Gene-Replacement Therapy (GRT) in Presymptomatic Spinal Muscular Atrophy (SMA): Study Update
Journal of Neurology, Neurosurgery and Psychiatry
Psychiatry
Mental Health
Neurology
Surgery
P.065 AVXS-101 Gene-Replacement Therapy (GRT)) in Presymptomatic Spinal Muscular Atrophy (SMA): Study Update
Canadian Journal of Neurological Sciences
Medicine
Neurology
066 Avxs-101 Gene-Replacement Therapy (GRT) for Spinal Muscular Atrophy Type 1 (SMA1): Pivotal Phase 3 Study (STR1VE) Update
Journal of Neurology, Neurosurgery and Psychiatry
Psychiatry
Mental Health
Neurology
Surgery
Spinal Muscular Atrophy Type 1
Pediatric Critical Care Medicine
Child Health
Critical Care
Pediatrics
Perinatology
Intensive Care Medicine
Gene Therapy in Mouse Models of Spinal Muscular Atrophy :||Using SMN Gene Replacement to Address Biological Questions
Respiratory Management of the Infant With Type 1 Spinal Muscular Atrophy
Archives of Disease in Childhood
Child Health
Pediatrics
Perinatology
Spinal Muscular Atrophy With Respiratory Distress Type 1—A Child With Atypical Presentation
Child Neurology Open
Pnd41 - Healthcare Costs of Patients With Spinal Muscular Atrophy
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
